Compagnie Lombard Odier SCmA’s Bristol-Myers Squibb BMY Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$121K	Hold	2,000	–	–	﹤0.01%	283
2025 Q4	$108K	Sell	2,000 -238,000	-99%	-$11.4M	﹤0.01%	296
2025 Q3	$10.8M	Hold	240,000	–	–	0.12%	84
2025 Q2	$11.1M	Sell	240,000 -435	-0.2%	-$21.4K	0.15%	72
2025 Q1	$14.7M	Hold	240,435	–	–	0.18%	78
2024 Q4	$13.6M	Hold	240,435	–	–	0.2%	68
2024 Q3	$12.4M	Hold	240,435	–	–	0.19%	70
2024 Q2	$9.99M	Hold	240,435	–	–	0.17%	75
2024 Q1	$13M	Buy	240,435 +175,400	+270%	+$8.94M	0.23%	75
2023 Q4	$3.34M	Buy	65,035 +62,600	+2,571%	+$3.29M	0.06%	126
2023 Q3	$141K	Buy	2,435 +2,000	+460%	+$123K	﹤0.01%	317
2023 Q2	$27.8K	Hold	435	–	–	﹤0.01%	465
2023 Q1	$30.1K	Hold	435	–	–	﹤0.01%	490
2022 Q4	$31K	Hold	435	–	–	﹤0.01%	537
2022 Q3	$31K	Sell	435 -1,300	-75%	-$94.3K	﹤0.01%	503
2022 Q2	$133K	Hold	1,735	–	–	﹤0.01%	349
2022 Q1	$127K	Sell	1,735 -1,040	-37%	-$69.8K	﹤0.01%	356
2021 Q4	$173K	Buy	2,775 +415	+18%	+$24.3K	﹤0.01%	385
2021 Q3	$140K	Sell	2,360 -3,000	-56%	-$198K	﹤0.01%	395
2021 Q2	$358K	Buy	5,360 +1,165	+28%	+$76K	0.01%	277
2021 Q1	$265K	Sell	4,195 -165	-4%	-$10.3K	0.01%	354
2020 Q4	$270K	Sell	4,360 -15,700	-78%	-$965K	0.01%	300
2020 Q3	$1.21M	Buy	20,060 +7,970	+66%	+$480K	0.04%	139
2020 Q2	$712K	Hold	12,090	–	–	0.02%	162
2020 Q1	$675K	Sell	12,090 -16,120	-57%	-$985K	0.03%	157
2019 Q4	$1.81M	Sell	28,210 -807	-3%	-$46.2K	0.07%	115
2019 Q3	$1.47M	Sell	29,017 -3,000	-9%	-$141K	0.06%	114
2019 Q2	$1.45M	Buy	32,017 +19,318	+152%	+$900K	0.06%	126
2019 Q1	$605K	Sell	12,699 -267,400	-95%	-$13.3M	0.03%	181
2018 Q4	$14.6M	Buy	280,099 +13,099	+5%	+$704K	0.6%	44
2018 Q3	$16.6M	Sell	267,000 -1,800	-0.7%	-$107K	0.58%	45
2018 Q2	$14.9M	Buy	268,800 +29,800	+12%	+$1.61M	0.55%	49
2018 Q1	$15.1M	Sell	239,000 -291,940	-55%	-$18.8M	0.55%	49
2017 Q4	$32.5M	Buy	530,940 +267,370	+101%	+$16.7M	0.58%	46
2017 Q3	$16.8M	Buy	263,570 +5,500	+2%	+$321K	0.6%	44
2017 Q2	$14.4M	Sell	258,070 -20,609	-7%	-$1.12M	0.5%	50
2017 Q1	$15.2M	Buy	278,679 +34,164	+14%	+$1.87M	0.51%	47
2016 Q4	$14.3M	Sell	244,515 -850	-0.3%	-$46.5K	0.42%	56
2016 Q3	$13.2M	Sell	245,365 -1,700	-0.7%	-$109K	0.39%	59
2016 Q2	$18.2M	Sell	247,065 -5,051	-2%	-$357K	0.53%	46
2016 Q1	$16.1M	Sell	252,116 -4,878	-2%	-$308K	0.49%	46
2015 Q4	$17.7M	Sell	256,994 -4,504	-2%	-$298K	0.56%	41
2015 Q3	$15.5M	Buy	261,498 +368	+0.1%	+$23.3K	0.63%	36
2015 Q2	$17.4M	Sell	261,130 -4,600	-2%	-$303K	0.65%	36
2015 Q1	$17.1M	Sell	265,730 -1,341	-0.5%	-$84K	0.65%	36
2014 Q4	$15.8M	Sell	267,071 -48,475	-15%	-$2.73M	0.73%	30
2014 Q3	$16.1M	Buy	315,546 +15,215	+5%	+$760K	0.65%	32
2014 Q2	$14.6M	Sell	300,331 -729	-0.2%	-$35.9K	0.58%	36
2014 Q1	$15.6M	Sell	301,060 -368	-0.1%	-$19.6K	0.65%	34
2013 Q4	$16M	Buy	+301,428	New	+$15.4M	0.67%	33

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Compagnie Lombard Odier SCmA's BMY Position: Q1 2026 in Review

Compagnie Lombard Odier SCmA held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 2,000 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #283.

Compagnie Lombard Odier SCmA first reported a position in BMY in Q4 2013 and has held it in 50 quarters since. The position peaked at $32.5M in Q4 2017. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Compagnie Lombard Odier SCmA held 2,000 shares of Bristol-Myers Squibb worth $121K as of Q1 2026.
Compagnie Lombard Odier SCmA left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up ﹤0.01% of Compagnie Lombard Odier SCmA's portfolio in Q1 2026, its #283 holding.
Compagnie Lombard Odier SCmA first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 50 quarters since.
Compagnie Lombard Odier SCmA's Bristol-Myers Squibb position peaked at $32.5M in Q4 2017.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2026, filed 15 Apr 2026.